Naturally occurring autoantibodies to apoptotic cells

Advances in Experimental Medicine and Biology

Volumn 750, Issue , 2012, Pages 14-26

  Elkon, Keith B ^a   Silverman, Gregg J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MALONALDEHYDE; MEMBRANE ANTIGEN; PHOSPHATIDYLSERINE; PHOSPHORYLCHOLINE; COMPLEMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; COMPLEMENT CLASSICAL PATHWAY; DENDRITIC CELL; DISEASE ACTIVITY; HUMAN; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; ANIMAL; COMPLEMENT ACTIVATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALONDIALDEHYDE; MICE; OXIDATION-REDUCTION; PHAGOCYTOSIS; PHOSPHORYLCHOLINE;

EID: 84866786258     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3461-0_2     Document Type: Article

References (53)

1. Casali P, Schettino EW. Structure and function of natural antibodies. Curr Top Microbiol Immunol 1996; 210:167-79. PMID:8565555 (Pubitemid 26024271)
2. Hayakawa K, Hardy RR. Normal, autoimmune, and malignant CD5+ B-cells: The LY-1 B lineage? Annu Rev Immunol 1988; 6:197-218. PMID:3289567 doi:10.1146/annurev.iy.06.040188.001213 (Pubitemid 19141582)
3. Foerster J. Autoimmune hemolytic anemias. In: Lee G et al., eds. Wintrobe's Clinical Hematology, 9th ed. Philadelphia: Lea and Febiger, 1993:1170-1196.
4. Thurnheer MC, Zuercher AW, Cebra JJ et al. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice. J Immunol 2003; 170:4564-71. PMID:12707334 (Pubitemid 36519962)
5. Briles DE, Nahm M, Schroer K et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med 1981; 153:694-705. PMID:7252411 doi:10.1084/jem.153.3.694 (Pubitemid 11155803)
6. Baumgarth N, Herman OC, Jager GC et al. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-80. PMID:10899913 doi:10.1084/jem.192.2.271 (Pubitemid 30470309)
7. Erwig LP, Henson PM. Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 2007; 171:2-8. PMID:17591947 doi:10.2353/ajpath.2007. 070135 (Pubitemid 47339220)
8. Chen Y, Park YB, Patel E et al. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 2009; 182:6031-43. PMID:19414754 doi:10.4049/jimmunol.0804191
9. Mercolino TJ, Arnold LW, Hawkins LA et al. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B-cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J Exp Med 1988; 168:687-98. PMID:3045250 doi:10.1084/ jem.168.2.687
10. Hayakawa K, Hardy RR, Honda M et al. Ly-1 B-cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci USA 1984; 81:2494-8. PMID:6609363 doi:10.1073/pnas.81.8.2494
11. Cox KO, Hardy SJ. Autoantibodies against mouse bromelain-modified RBC are specifically inhibited by a common membrane phospholipid, phosphatidylcholine. Immunology 1985; 55:263-9. PMID:4007927 (Pubitemid 15003191)
12. Mercolino TJ, Arnold LW, Haughton G. Phosphatidyl choline is recognized by a series of Ly-1+ murine B-cell lymphomas specific for erythrocyte membranes. J Exp Med 1986; 163:155-65. PMID:2416866 doi:10.1084/jem.163.1.155 (Pubitemid 16189517)
13. Pisetsky DS. Anti-DNA and autoantibodies. Curr Opin Rheumatol 2000; 12:364-8. PMID:10990170 doi:10.1097/00002281-200009000-00002
14. Rovere P, Manfredi AA, Vallinoto C et al. Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J Autoimmun 1998; 11:403-11. PMID:9802923 doi:10.1006/ jaut.1998.0224
15. Sorice M, Circella A, Misasi R et al. Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin Exp Immunol 2000; 122:277-84. PMID:11091286 doi:10.1046/ j.1365-2249.2000.01353.x
16. Elkon KB. Cell survival and death in the rheumatic diseases. In: Firestein GS, Budd RC et al., eds. Kelley's Textbook of Rheumatology, 6th ed. Philadelphia: W.B. Saunders Company, 2009:379-395.
17. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T-lymphocytes. J Exp Med 1995; 182:1597-601. PMID:7595231 doi:10.1084/jem.182.5.1597
18. Jiang J, Serinkan BF, Tyurina YY et al. Peroxidation and externalization of phosphatidylserine associated with release of cytochrome c from mitochondria. Free Radic Biol Med 2003; 35:814-25. PMID:14583346 doi:10.1016/S0891-5849(03) 00429-5 (Pubitemid 37329485)
19. Greenberg ME, Sun M, Zhang R et al. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 2006; 203:2613-25. PMID:17101731 doi:10.1084/jem. 20060370 (Pubitemid 44833338)
20. Kim SJ, Gershov D, Ma X et al. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002; 196:655-65. PMID:12208880 doi:10.1084/jem.20020542 (Pubitemid 35024443)
21. Lauber K, Bohn E, Krober SM et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113:717-30. PMID:12809603 doi:10.1016/ S0092-8674(03)00422-7
22. Chen R, Roman J, Guo J et al. Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells. Stem Cells Dev 2006; 15:797-804. PMID:17253943 doi:10.1089/scd.2006.15.797 (Pubitemid 46147852)
23. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010; 140:619-30. PMID:20211132 doi:10.1016/j.cell.2010.02.014
24. Chou MY, Fogelstrand L, Hartvigsen K et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009; 119:1335-49. PMID:19363291 doi:10.1172/ JCI36800
25. Sørensen UB, Henrichsen J. Cross-reactions between pneumococci and other streptococci due to C polysaccharide and F antigen. J Clin Microbiol 1987; 25:1854-9. PMID:3499450 (Pubitemid 17149255)
26. Mi QS, Zhou L, Schulze DH et al. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc Natl Acad Sci USA 2000; 97:6031-6. PMID:10811914 doi:10.1073/pnas.110039497 (Pubitemid 30367518)
27. Chen Y, Khanna S, Goodyear CS et al. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 2009; 183:1346-59. PMID:19564341 doi:10.4049/jimmunol.0900948
28. Etlinger HM, Heusser CH. T15 dominance in BALB/c mice is not controlled by environmental factors. J Immunol 1986; 136:1988-91. PMID:3485136
29. Palinski W, Horkko S, Miller E et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996; 98:800-14. PMID:8698873 doi:10.1172/JCI118853 (Pubitemid 26349186)
30. Shaw PX, Horkko S, Chang MK et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105:1731-40. PMID:10862788 doi:10.1172/JCI8472 (Pubitemid 30421754)
31. Chang MK, Bergmark C, Laurila A et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 1999; 96:6353-8. PMID:10339591 doi:10.1073/pnas.96.11.6353 (Pubitemid 29256669)
32. Shaw PX, Goodyear CS, Chang MK et al. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol 2003; 170:6151-7. PMID:12794145 (Pubitemid 36682598)
33. Mevorach D, Zhou J-L, Song X et al. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188:387-92. PMID:9670050 doi:10.1084/jem.188.2.387 (Pubitemid 28357766)
34. Matsuura E, Igarashi Y, Yasuda T et al. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457-62. PMID:7507506 doi:10.1084/jem.179.2.457 (Pubitemid 24058733)
35. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306. PMID:16420554 doi:10.1111/j.1538-7836.2006.01753.x
36. Guerin J, Casey E, Feighery C et al. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Autoimmunity 1999; 31:109-16. PMID:10680749 doi:10.3109/08916939908994054 (Pubitemid 30110400)
37. Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10:1222-6. PMID:15489858 doi:10.1038/nm1121 (Pubitemid 39540439)
38. Mehrani T, Petri M. Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. J Rheumatol 2011; 38:64-8. PMID:20952463 doi:10.3899/jrheum.100568
39. Mevorach D, Mascarenhas J, Gershov DA et al. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998; 188:2313-20. PMID:9858517 doi:10.1084/jem.188.12.2313 (Pubitemid 29028503)
40. Gershov D, Kim S, Brot N et al. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components and sustains an antiinflammatory innate immune response. Implications for systemic autoimmunity. J Exp Med 2000; 192:1353-64. PMID:11067883 doi:10.1084/ jem.192.9.1353
41. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. J Immunol 1997; 158:4525-8. PMID:9144462
42. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19:56-9. PMID:9590289 doi:10.1038/ng0598-56 (Pubitemid 28242023)
43. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000; 191:1253-8. PMID:10748243 doi:10.1084/ jem.191.7.1253
44. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 2000; 37:1141-9. PMID:11451419 doi:10.1016/S0161-5890(01)00025-6
45. Quartier P, Potter PK, Ehrenstein MR et al. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol 2005; 35:252-60. PMID:15597324 doi:10.1002/eji.200425497 (Pubitemid 40123872)
46. Ogden CA, Kowalewski R, Peng YF et al. IgM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 2005; 38:259-64. PMID:16206508 doi:10.1080/08916930500124452 (Pubitemid 40974955)
47. Czajkowsky DM, Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc Natl Acad Sci USA 2009; 106:14960-5. PMID:19706439 doi:10.1073/pnas.0903805106
48. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711. PMID:12615891 doi:10.1146/annurev.immunol.21. 120601.141040 (Pubitemid 37174545)
49. Santer DM, Hall BE, George TC et al. C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J Immunol 2010; 185:4738-49. PMID:20844193 doi:10.4049/jimmunol.1001731
50. Gray M, Miles K, Salter D et al. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B-cells. Proc Natl Acad Sci USA 2007; 104:14080-5. PMID:17715067 doi:10.1073/ pnas.0700326104 (Pubitemid 350003338)
51. Silverman GJ. Regulatory natural autoantibodies to apoptotic cells: Pallbearers and protectors. Arthritis Rheum 2011; 63:597-602. PMID: 21360488, doi: 10.1002/art.30140.
52. Anania C, Gustafsson T, Hua X et al. Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus. Arthritis Res Ther 2010; 12:R214. PMID:21092251 doi:10.1186/ar3193
53. Ogden CA, deCathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194:781-95. PMID:11560994 doi:10.1084/jem.194.6.781 (Pubitemid 32983014)